跳至主要内容
临床试验/NCT02837731
NCT02837731已完成不适用

Evaluation of Fluid Volume in Patients With Sepsis and Refractory Hypotension

Cheetah Medical Inc.23 个研究点 分布在 2 个国家目标入组 150 人开始时间: 2016年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
150
试验地点
23
主要终点
Fluid Balance

研究概览

简要总结

This study assesses the mean difference in fluid balance at ICU discharge and associated patient outcomes, based on a dynamic assessment of fluid responsiveness in septic patients with refractory hypotension in an ICU setting.

详细描述

Multi-center randomized study comparing dynamic assessment of fluid responsiveness utilizing Starling SV monitor compared to a control group.

Subjects will be randomized in a 2:1 treatment to control group ratio to increase power for sub-analysis by patient population.

Patients randomized to the Starling SV arm will have treatment guided by a dynamic assessment of fluid responsiveness (measured by a change in stroke volume index > 10%) as assessed by passive leg raise (PLR).

Patients randomized to the control group will receive standard of care treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of sepsis, as exhibited by 2 or more of the following systemic inflammatory response syndrome (SIRS) criteria and a known or presumed infection at time of screening:
  • Temperature of > 38 C or < 36 C
  • Heart rate of > 90/min
  • Respiratory rate of > 20/min or PaCO2 < 32 mm Hg (4.3 kPA)
  • White blood cell count > 12000/mm3 or < 4000/mm3 or >10% immature bands
  • Refractory hypotension despite initial fluid resuscitation (1L of treatment fluid)
  • Patient enrolled in study as soon as possible (ideal window of 0-12 hours) and within 24 hours of arrival to the hospital
  • Anticipated ICU admission
  • Able to provide signed informed consent or consent can be obtained from the patient's authorized representative

排除标准

  • Primary diagnosis of: acute cerebral vascular event, acute coronary syndrome, acute pulmonary edema, status asthmaticus, major cardiac arrhythmia, drug overdose, or injury from burn or trauma
  • Known aortic insufficiency, or aortic abnormalities
  • Hemodynamic instability due to active gastrointestinal hemorrhage
  • Patient has received >3 liters of IV fluid prior to study randomization
  • Requires immediate surgery
  • Patient transferred to the ICU from another hospital unit
  • Do not attempt resuscitation (DNAR or DNR) order
  • Advanced directives restricting implementation of the resuscitation protocol
  • Contraindication to blood transfusion
  • Attending clinician deems aggressive resuscitation unsuitable
  • Transferred from another in-hospital setting
  • Not able to commence treatment protocol within 1 hour after randomization
  • Known intraventricular heart defect, such as ventral septal defect or atrial septal defect
  • Use of additional hemodynamic monitoring involving stroke volume variation (SVV) to determine fluid responsiveness
  • Seizure in the last 24 hours
  • Known allergy to sensor material or gel
  • Inability or contraindication to doing a passive leg raise with both extremities, such as inability to interrupt venous compression boots
  • Patient has an epidural catheter in place
  • Suspected intra-abdominal hypertension
  • Inability to obtain IV access
  • Diabetic ketoacidosis
  • Hyper-osmolarity syndrome
  • Patient uncouples from treatment algorithm
  • Patient should be excluded based on the opinion of the Clinician/Investigator

结局指标

主要结局

Fluid Balance

时间窗: 72 hours

Fluid balance is defined as all intravenous fluids administered over a 72 hour period (or ICU discharge, whichever occurred first), minus all fluid output. Urine output was measured in the ICU in 12 hour increments.

次要结局

  • Percentage of Participants Requiring Renal Replacement Therapy(Day 1 to Day 30)
  • Percentage of Participants Requiring Ventilator Use(Day 1 to Day 30)
  • Number of Hours of Ventilator Use(Day 1 to Day 30)
  • Number of Hours of Vasopressor Use(Day 1 to Day 30)
  • Length of ICU Stay(Day 1 to Day 30)
  • Change From Baseline in Serum Creatinine Levels at 72 Hours(Baseline, 72 hours)

研究者

发起方
Cheetah Medical Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (23)

Loading locations...

相似试验

Fluid Responsiveness Evaluation in Sepsis-associated... | 临床试验